Hydroxyzine with Lamictal for Short-Term Insomnia
While hydroxyzine can be safely taken with lamotrigine from a drug interaction standpoint, hydroxyzine is not recommended as a treatment for insomnia based on current clinical practice guidelines.
Safety of Concurrent Use
From a drug safety perspective, there are no significant pharmacokinetic interactions between hydroxyzine and lamotrigine. The FDA label for hydroxyzine warns about potentiation with CNS depressants 1, but lamotrigine is not classified as a CNS depressant. The Lamictal label does not list hydroxyzine as having any interaction with lamotrigine 2. Therefore, concurrent use is pharmacologically safe for a patient stable on lamotrigine.
Important Safety Considerations for Hydroxyzine:
- QT prolongation risk: Use caution in patients with cardiac risk factors, electrolyte imbalances, or those on other QT-prolonging medications 1
- CNS depression: Warn patients about drowsiness and avoid alcohol or other sedatives 1
- Anticholinergic effects: Particularly problematic in elderly patients (dry mouth, confusion, urinary retention) 1
The Problem: Hydroxyzine Is Not Guideline-Recommended for Insomnia
The American Academy of Sleep Medicine explicitly recommends against using antihistamines (including hydroxyzine) for chronic insomnia due to lack of efficacy and safety data 3. The 2017 AASM guideline specifically recommends against diphenhydramine (another antihistamine) for insomnia 4, and this recommendation extends to the antihistamine class.
The 2020 VA/DoD guidelines similarly advise against antihistamines for chronic insomnia, noting that tolerance develops after 3-4 days of continuous use, limiting even short-term benefit 5.
Evidence on Hydroxyzine for Insomnia:
A 2023 systematic review found only mixed efficacy for hydroxyzine in treating insomnia, with limited data from just 5 small studies 6. The authors concluded it "could be considered" only when previous therapy failed, was not tolerated, or contraindicated—a far cry from a strong recommendation.
Recommended Alternatives for Short-Term Insomnia
For short-term insomnia in an adult stable on lamotrigine, the guideline-recommended sequence is:
First-line: Short-intermediate acting benzodiazepine receptor agonists (BzRAs) or ramelteon 3:
Second-line: Low-dose sedating antidepressants (if comorbid depression/anxiety):
Behavioral interventions: Should supplement any pharmacotherapy 3
Special Consideration: Lamotrigine and Insomnia
Be aware that lamotrigine itself can cause insomnia in approximately 6% of patients 7. This appears to be dose-dependent 7. If the patient's insomnia began or worsened after starting lamotrigine, consider whether dose adjustment or timing of administration might help before adding another medication. Insomnia is listed as a common adverse event with lamotrigine 8, 9.
Clinical Decision Algorithm
If you're considering hydroxyzine despite guideline recommendations:
- First, verify: Has the patient tried guideline-recommended options (BzRAs, ramelteon)?
- Second, assess: Are there contraindications to preferred agents (e.g., sleep apnea, substance use history)?
- Third, evaluate cardiac risk: Check for QT prolongation risk factors before prescribing hydroxyzine 1
- Fourth, set expectations: Explain this is off-guideline, tolerance may develop quickly, and efficacy is uncertain 5, 6
- Fifth, plan short duration: Use for days, not weeks, given rapid tolerance development 5
Common Pitfalls to Avoid
- Don't assume antihistamines are "safer" because they're available OTC—they lack efficacy data and have significant anticholinergic side effects 3, 5
- Don't overlook lamotrigine as the culprit if insomnia is new or worsening 7
- Don't forget cardiac screening before hydroxyzine use 1
- Don't use hydroxyzine long-term given rapid tolerance development 5
In summary: While hydroxyzine can be safely combined with lamotrigine, it should not be your first, second, or even third choice for treating insomnia based on current evidence-based guidelines.